"More Than Just a Weight-Loss Drug: Do GLP-1 Receptor Agonists Have Anti-Cancer Potential?"

Obstetrics & Gynecology Grand Rounds

Thursday, December 11, 2025 at 7:00 AM


This grand round has already taken place.


Online Streaming
December 11th, 2025
1.00 AMA PRA Category 1 Credit Hours

Description

Dr. Velasquez gave grand rounds this week on "More Than Just a Weight-Loss Drug: Do GLP-1 Receptor Agonists Have Anti-Cancer Potential?"

Dates and Times

Start: 12/11/2025 7:00 AM
End: 12/11/2025 8:00 AM

Objectives

Review endometrial cancer risk factors and underlying mechanisms of risk.
Review GLP-1 receptor agonists and cancer risk.
Discuss potential mechanisms underlying the impact of GLP-1 receptor agonists on cancer risk

Speakers

  • Jessica Velasquez, MD
    • More Than Just a Weight-Loss Drug: Do GLP-1 Receptor Agonists Have Anti-Cancer Potential?

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Need help with this Grand Round Session?

Please contact the Grand Round coordinator listed below:

Taylor Myers
Department: Obstetrics and Gynecology
Phone: (614) 814-1530
Email: mye241@osumc.edu